by Regina E. Herzlinger - Publications - Faculty & Research - Harvard Business School

Filter Results: (503)

Filter Results: (503)

Show Results For

← Page 22 of 503 Results →

September 2012 (Revised August 2015)
Case

Shanghai Pharmaceuticals

By: Regina E. Herzlinger and Natalie Kindred

Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details

Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe

May 2012 (Revised August 2014)
Case

McKesson

By: Regina E. Herzlinger and Natalie Kindred

McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details

Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Pharmaceutical Industry; Health Industry; United States

March 2011
Article

An Angel Investor with an Agenda

By: Regina E. Herzlinger and Beatriz Muñoz-Seca

Keywords: Investment

Find at Harvard

January 2010 (Revised August 2012)
Background Note

Note on Telemedicine

By: Regina E. Herzlinger and Jillian Copeland

This note provides background in all the modalities of telemedicine. It accompanies the cases "Medtronic: Patient Management Initiative" (A) and (B), HBS Nos. 302-005 and 309-064. View Details

Keywords: Interactive Communication; Entrepreneurship; Health Care and Treatment; Technological Innovation; Information Technology; Health Industry; Telecommunications Industry

November 2003 (Revised December 2007)
Supplement

Circle Gastroenterology Products (B)

By: Regina E. Herzlinger and James Weber

Supplements the (A) case. View Details

Keywords: Product Development; Marketing Strategy; Medical Devices and Supplies Industry

August 2001 (Revised August 2012)
Case

BestDoctors, Inc.

By: Regina E. Herzlinger and Seth Bokser

Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into... View Details

Keywords: Business Model; Entrepreneurship; Health Care and Treatment; Medical Specialties; Knowledge Sharing; Demand and Consumers; Health Industry

17 Dec 2013
First Look

First Look: December 17

Publications August 2013 Harvard Business Review Press Can China Lead? Reaching the Limits of Power and Growth By: Abrami, Regina M., William C. Kirby, and F. Warren McFarlan Abstract—At the time of the American Revolution, China was... View Details

Keywords: Carmen Nobel

8 Sep 2020
Interview

The U.S. Health Care System: From Dysfunction to Functioning

By: Regina E. Herzlinger and Edward Shin

February 2018
Case

Health Savings Accounts: Enabling Consumer Participation

By: Regina E. Herzlinger and James Wallace

Health savings accounts (HSAs), a creation of the 2003 Medicare Modernization Act, had become an integral part of the drive toward consumer-driven health care. Coupled with high-deductible health plans, HSAs allowed consumers to directly control a significant part of... View Details

Keywords: Health Care; Healthcare Costs; Health Insurance; Health Care and Treatment; Cost; Insurance; Innovation and Invention; Health Industry; United States

March 2015 (Revised February 2022)
Supplement

CV Ingenuity (B): Epilogue

By: Regina E. Herzlinger and Andrew Otazo

Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors? The... View Details

April 1995 (Revised August 1995)
Supplement

Empire Blue Cross and Blue Shield (D)

By: Regina E. Herzlinger and Ramona Hilgenkamp

Supplements the (A) case. View Details

Keywords: Insurance Industry; Health Industry

April 1995 (Revised December 2006)
Case

Identify the Nonprofit

By: Regina E. Herzlinger and Ramona Hilgenkamp

This case presents financial statements and selected ratios for seven unidentified nonprofit organizations and asks that each set of financial information be matched with one of the following nonprofit entities: a public television station, a suburban hospital, a... View Details

Keywords: Nonprofit Organizations; Financial Statements

February 1995
Background Note

Health Information Industry Note

By: Regina E. Herzlinger and VJ Pappas

Keywords: Health; Information

Find at Harvard

August 2013 (Revised August 2014)
Technical Note

Population Health Management—Techniques and Tools

By: Regina E. Herzlinger and Kyle Bertke

Companion note to "Amil and the Health Care System in Brazil," Harvard Business School Case No. 312-029, January 2014 View Details

March 2010
Supplement

Boston Scientific Corporation (B)

By: Regina E. Herzlinger and Charlie Attlan

The case provides the denoument for Boston Scientific Corporation (A) HBS No. 310079. View Details

Keywords: Medical Devices and Supplies Industry

March 2008 (Revised January 2010)
Background Note

Note on Accountability in the U.S. Health Care System

By: Regina E. Herzlinger and Michael Millenson

This note explains how health care providers, health insurers, and consumers are held accountable for their performance and the entrepreneurial opportunities thus created. View Details

Keywords: Entrepreneurship; Ethics; Insurance; Corporate Accountability; Health Care and Treatment; Demand and Consumers; Health Industry; United States

February 2008 (Revised August 2012)
Background Note

Note on Medical Travel

By: Regina E. Herzlinger and Sara Green

Background notes for MedVal and Fortis case studies. View Details

Keywords: Cost; Health Care and Treatment; Cross-Cultural and Cross-Border Issues; Health Industry; Tourism Industry; India

June 2005 (Revised August 2006)
Exercise

New Sector Alliance (B)

By: Regina E. Herzlinger and Louisa Neissa

Supplements the (A) case. View Details

Keywords: Health Care and Treatment; Policy; United States

Find at Harvard

June 2003 (Revised March 2008)
Case

Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

By: Regina E. Herzlinger and Marc Aquino

Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details

Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry

September 2002 (Revised January 2013)
Case

MedCath Corporation (A)

By: Regina E. Herzlinger and Pete Stavros

MedCath is a horizontally integrated chain of heart hospitals that partners with local cardiologists. It claims that its focus leads to better and cheaper results than those of an everything-for-everybody general hospital. Community hospitals generally vehemently... View Details

Keywords: Medical Specialties; Market Entry and Exit; Service Delivery; Conflict and Resolution; Horizontal Integration; Health Industry

←
22
23
24
25
26
→